Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke

Clinical trial NCT07241520 · RECRUITING

Trial details

NCT number: NCT07241520
Sponsor: Shanghai Hutchison Pharmaceuticals Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2025-12-08
Primary completion: 2027-06-30
Enrollment: 1096

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.